Breeze Acquisition II (BREZ) vs Moolec Science SA (MLEC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BREZ | MLEC |
|---|---|---|
| Share price | $10.07 | $4.19 |
| Market cap | — | $3.04M |
| 1-day change | +0.19% | -12.89% |
| EPS (TTM) | — | $-199.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.07 | $23.22 |
| 52-week low | $9.90 | $3.08 |
| Distance from 52-week high | -0.01% | -81.96% |
| Average volume | 28.56K | 17.09K |
| Shares outstanding | 17.69M | 726.12K |
| Sector | Finance | Healthcare |
| Industry | Blank Checks | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Breeze Acquisition II in Finance and Moolec Science SA in Healthcare.
About Moolec Science SA
MLEC stock →Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Healthcare · Biotechnology
BREZ vs MLEC FAQ
Are Breeze Acquisition II and Moolec Science SA in the same industry?
No. Breeze Acquisition II is in the Finance sector, while Moolec Science SA is in Healthcare.